High Katherine A 4
4 · CRISPR Therapeutics AG · Filed Jun 15, 2020
Insider Transaction Report
Form 4
High Katherine A
Director
Transactions
- Award
Stock Option (Right to Buy)
2020-06-11+15,000→ 15,000 totalExercise: $59.70Exp: 2030-06-11→ Common Stock (15,000 underlying)
Footnotes (1)
- [F1]This option was granted on June 11, 2020 with respect to 15,000 Common Shares with 100% of the shares vesting in 12 equal monthly installments on the final day of each succeeding calendar month occurring after the grant date provided that the first installment vests on June 30, 2020 and the last installment vests on the earlier of (i) the one year anniversary of the date of grant or (ii) the date of the 2021 Annual General Meeting of Shareholders.